(Q50886876)

24 March 2018

title

Is the haematopoietic effect of testosterone mediated by erythropoietin? The results of a clinical trial in older men. (English)

1 reference

24 March 2018

1 reference

1 reference

1 reference

3

1 reference

24 March 2018

Fulvio Lauretani

10

1 reference

24 March 2018

author name string

M Maggio

1

1 reference

24 March 2018

P J Snyder

2

1 reference

24 March 2018

Y Milaneschi

4

1 reference

24 March 2018

M Luci

5

1 reference

24 March 2018

C Cattabiani

6

1 reference

24 March 2018

S Masoni

7

1 reference

24 March 2018

A Vignali

8

1 reference

24 March 2018

R Volpi

9

1 reference

24 March 2018

H Peachey

11

1 reference

24 March 2018

G Valenti

12

1 reference

24 March 2018

A R Cappola

13

1 reference

24 March 2018

D Longo

14

1 reference

24 March 2018

L Ferrucci

15

1 reference

24 March 2018

publication date

9 October 2012

1 reference

24 March 2018

published in

Andrology

1 reference

24 March 2018

volume

1

1 reference

24 March 2018

issue

1

1 reference

24 March 2018

page(s)

24-28

1 reference

24 March 2018

Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.2047-2927.2012.00009.X

Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2047-2927.2012.00009.X

Risks versus benefits of testosterone therapy in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2047-2927.2012.00009.X

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2047-2927.2012.00009.X

Transdermal androgen therapy to augment EPO in the treatment of anemia of chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2047-2927.2012.00009.X

Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2047-2927.2012.00009.X

Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2047-2927.2012.00009.X

Erythropoietin, erythropoiesis and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2047-2927.2012.00009.X

Effects of graded doses of testosterone on erythropoiesis in healthy young and older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2047-2927.2012.00009.X

Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2047-2927.2012.00009.X

Low testosterone levels and the risk of anemia in older men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2047-2927.2012.00009.X

Low testosterone and anaemia in men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2047-2927.2012.00009.X

Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2047-2927.2012.00009.X

Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2047-2927.2012.00009.X

Testosterone membrane-initiated action in breast cancer cells: Interaction with the androgen signaling pathway and EPOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2047-2927.2012.00009.X

Androgens and erythropoiesis: past and present

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2047-2927.2012.00009.X

Androgens and Erythropoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2047-2927.2012.00009.X

Effect of testosterone treatment on bone mineral density in men over 65 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2047-2927.2012.00009.X

AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2047-2927.2012.00009.X

10.1111/J.2047-2927.2012.00009.X

21 January 2018

Identifiers

DOI

1 reference

24 March 2018

release_ctxktgvvdjcnzkx25fecrtjhtm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ctxktgvvdjcnzkx25fecrtjhtm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

24 March 2018